Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering

Core Insights - Onco-Innovations Limited has engaged a U.S. investment bank as its capital markets advisor for a potential cross-listing on the Nasdaq Stock Market [1] - The company is also evaluating and structuring a potential concurrent equity financing, although the terms have not yet been finalized [1] Company Actions - The engagement of a capital markets advisor indicates Onco's strategic move to enhance its market presence through a Nasdaq listing [1] - The potential concurrent equity financing suggests that the company is looking to raise additional capital to support its growth initiatives [1]